Buckingham Capital Management (Ohio)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-18,594
Closed -$1.33M 141
2017
Q4
$1.33M Sell
18,594
-585
-3% -$44.4K 0.28% 87
2017
Q3
$1.55M Sell
19,179
-105
-0.5% -$8.03K 0.34% 78
2017
Q2
$1.36M Sell
19,284
-255
-1% -$17K 0.31% 85
2017
Q1
$1.33M Buy
19,539
+1,280
+7% +$90K 0.31% 84
2016
Q4
$1.31M Buy
18,259
+5,746
+46% +$427K 0.32% 85
2016
Q3
$990K Buy
12,513
+899
+8% +$73K 0.25% 99
2016
Q2
$969K Sell
11,614
-151
-1% -$13.4K 0.26% 99
2016
Q1
$1.08M Buy
11,765
+2,952
+33% +$266K 0.3% 93
2015
Q4
$892K Buy
8,813
+1,110
+14% +$115K 0.25% 101
2015
Q3
$756K Buy
7,703
+1,292
+20% +$143K 0.22% 110
2015
Q2
$755K Buy
6,411
+238
+4% +$26K 0.21% 114
2015
Q1
$606K Sell
6,173
-100
-2% -$10.2K 0.17% 125
2014
Q4
$591K Buy
6,273
+30
+0.5% +$3.1K 0.18% 123
2014
Q3
$665K Sell
6,243
-360
-5% -$35.3K 0.21% 116
2014
Q2
$547K Sell
6,603
-50
-0.8% -$3.89K 0.17% 131
2014
Q1
$471K Hold
6,653
0.16% 138
2013
Q4
$500K Sell
6,653
-475
-7% -$33.1K 0.18% 128
2013
Q3
$453K Sell
7,128
-870
-11% -$52K 0.18% 128
2013
Q2
$410K Buy
+7,998
New +$417K 0.17% 130

Other funds holding GILD

Buckingham Capital Management (Ohio)'s GILD Position: Q1 2018 in Review

Buckingham Capital Management (Ohio) sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 18,594 shares — an estimated $1.33M sold.

Buckingham Capital Management (Ohio) first reported a position in GILD in Q2 2013 and held it in 19 quarters. The position peaked at $1.55M in Q3 2017. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Buckingham Capital Management (Ohio) reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • Buckingham Capital Management (Ohio) sold 18,594 Gilead Sciences shares in Q1 2018, an estimated $1.33M.
  • Buckingham Capital Management (Ohio) first reported a position in Gilead Sciences in Q2 2013 and held it in 19 quarters.
  • Buckingham Capital Management (Ohio)'s Gilead Sciences position peaked at $1.55M in Q3 2017.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Buckingham Capital Management (Ohio)'s 13F filing for Q1 2018, filed 11 May 2018.